Omeros finance VP sells 10,000 shares on each of two days
The VP, Finance & CAO's reported sales were under a Rule 10b5-1 plan adopted February 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
OMEROS CORP (OMER) VP, Finance & CAO David J. Borges exercised options to acquire 10,000 shares on September 23, 2026, at $15.58 per share, and options for 5,000 shares each at $3.93 and $2.94 on September 22. He sold 10,000 shares on each date at $20.95 per share. Both sales were open-market sales under a Rule 10b5-1 trading plan adopted February 10, 2026.
Insider Trade Summary 10b5-1
Exercise and Sale: 20,000 shares ($229K approx. pre-tax spread)
Exercise and Sale
8 txns
Insider
Borges David J.
Role
VP, Finance & CAO
Sold
20,000 shs ($419K)
Approx. gross sale proceeds
$419K
Approx. exercise cost
$190K
Approx. pre-tax spread
$229K
Share of Position Sold
100%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F4 | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $15.58 | $156K |
| Sale | Common Stock F1 | 10,000 | $20.95 | $210K |
| Exercise | Stock Option (Right to Buy) F2 | 5,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F3 | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,000 | $3.93 | $20K |
| Exercise | Common Stock | 5,000 | $2.94 | $15K |
| Sale | Common Stock F1 | 10,000 | $20.95 | $210K |
Holdings After Transaction:
Stock Option (Right to Buy) — 24,094 options (Direct);
Common Stock — 0 shares (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 44,094 to 24,094 options (Direct);
Common Stock, 0 to 0 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
- F1. Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2026. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2. This option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vested and became exercisable on each monthly anniversary thereafter.
- F3. This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2023. Installments vest and become exercisable on each monthly anniversary thereafter.
- F4. This option vested and became exercisable with respect to 25% of the total number of shares subject to the option on the 12-month anniversary of the vesting commencement date of June 8, 2020, and the remainder of the option vested and became exercisable over 48 equal installments on each monthly anniversary thereafter.
Key Figures
Shares acquired through option exercise: 10,000 shares
Exercise price: $15.58 per share
Shares acquired through option exercise: 5,000 shares
+3 more
6 metrics
Shares acquired through option exercise
10,000 shares
September 23, 2026; exercise price $15.58 per share
Exercise price
$15.58 per share
Options exercised September 23, 2026
Shares acquired through option exercise
5,000 shares
September 22, 2026; exercise price $3.93 per share
Exercise price
$3.93 per share
Options exercised September 22, 2026
Shares acquired through option exercise
5,000 shares
September 22, 2026; exercise price $2.94 per share
Sale price
$20.95 per share
10,000 shares sold on each of September 22 and September 23, 2026
Key Terms
Rule 10b5-1 trading plan, exercise price, vesting commencement date
3 terms
Rule 10b5-1 trading plan regulatory
"pursuant to a previously established Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
exercise price financial
"exercise price of $15.58"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting commencement date financial
"vesting commencement date of June 8, 2020"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do David J. Borges's exercised OMER options expire?
The options exercised for 10,000 shares at $15.58 expire June 7, 2030; those exercised for 5,000 shares at $3.93 expire September 20, 2032; and those for 5,000 shares at $2.94 expire September 21, 2033.
AI-generated analysis. How Rhea-AI works. Not financial advice.
